TAK Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TAK) Institutional Ownership
What the institutions did with TAK last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Capital Research Global Investors | 19.3M | 18.5% |
| FMR LLC | 9.6M | 9.2% |
| MORGAN STANLEY | 7.0M | 6.7% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.1M | 5.8% |
| GOLDMAN SACHS GROUP INC | 5.1M | 4.9% |
| BRANDES INVESTMENT PARTNERS, LP | 4.5M | 4.4% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.7M | 3.6% |
| BlackRock, Inc. | 3.7M | 3.5% |
| RENAISSANCE TECHNOLOGIES LLC | 2.6M | 2.5% |
| Qube Research & Technologies Ltd | 2.2M | 2.1% |
| FIRST TRUST ADVISORS LP | 2.1M | 2.0% |
| D. E. Shaw & Co., Inc. | 2.0M | 2.0% |
| MANAGED ASSET PORTFOLIOS, LLC | 1.8M | 1.7% |
| NORTHERN TRUST CORP | 1.7M | 1.7% |
| VAN ECK ASSOCIATES CORP | 1.7M | 1.6% |
| ENVESTNET ASSET MANAGEMENT INC | 1.6M | 1.5% |
| AQR CAPITAL MANAGEMENT LLC | 1.5M | 1.5% |
| Quantinno Capital Management LP | 1.4M | 1.3% |
| WELLS FARGO & COMPANY/MN | 1.2M | 1.1% |
| MILLENNIUM MANAGEMENT LLC | 1.1M | 1.0% |
| UBS Group AG | 911.3K | 0.9% |
| Crossmark Global Holdings, Inc. | 783.8K | 0.8% |
| JPMORGAN CHASE & CO | 744.9K | 0.7% |
| STIFEL FINANCIAL CORP | 722.9K | 0.7% |
| BNP PARIBAS FINANCIAL MARKETS | 714.1K | 0.7% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| FMR LLC | Increased | 7.1M | 9.6M | +2.5M |
| Qube Research & Technologies Ltd | New | 0 | 2.2M | +2.2M |
| UBS Group AG | Reduced | 2.7M | 911.3K | -1.8M |
| MILLENNIUM MANAGEMENT LLC | New | 0 | 1.1M | +1.1M |
| Capital Wealth Planning, LLC | Sold Out | 886.8K | 0 | -886.8K |
| AQR CAPITAL MANAGEMENT LLC | Increased | 894.4K | 1.5M | +631.3K |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Increased | 3.1M | 3.7M | +616.6K |
| VAN ECK ASSOCIATES CORP | Reduced | 2.3M | 1.7M | -586.1K |
| D. E. Shaw & Co., Inc. | Reduced | 2.6M | 2.0M | -553.1K |
| MORGAN STANLEY | Increased | 6.5M | 7.0M | +525.3K |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 190.4K | 714.1K | +523.7K |
| BlackRock, Inc. | Increased | 3.2M | 3.7M | +511.7K |
| GOLDMAN SACHS GROUP INC | Reduced | 5.6M | 5.1M | -493.7K |
| CITADEL ADVISORS LLC | Reduced | 624.2K | 168.1K | -456.0K |
| PFM Health Sciences, LP | New | 0 | 444.2K | +444.2K |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 3.0M | 2.6M | -421.1K |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 6.4M | 6.1M | -374.2K |
| Balyasny Asset Management L.P. | Increased | 140.6K | 511.3K | +370.8K |
| JPMORGAN CHASE & CO | Increased | 454.0K | 744.9K | +290.9K |
| Hudson Bay Capital Management LP | New | 0 | 275.0K | +275.0K |
| Walleye Capital LLC | Reduced | 260.8K | 15.5K | -245.3K |
| Trexquant Investment LP | Sold Out | 229.5K | 0 | -229.5K |
| NORTHERN TRUST CORP | Reduced | 2.0M | 1.7M | -220.7K |
| Focus Partners Wealth | Increased | 482.4K | 680.0K | +197.6K |
| Capital Research Global Investors | Increased | 19.1M | 19.3M | +193.5K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.